Journal article

Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review

Riley Batchelor, Julia Fiona-Maree Gilmartin, William Kemp, Ingrid Hopper, Danny Liew

Journal of Gastroenterology and Hepatology | WILEY | Published : 2017


BACKGROUND AND AIM: Proton pump inhibitors (PPIs) are among the most widely used medications worldwide. Dementia is an increasingly common cause of disability in older populations. Recent studies have suggested an increased risk of cognitive impairment and dementia diagnosis among people who consume PPIs. This systematic review explores dementia, cognitive impairment, and the use of PPIs. METHODS: Systematic searches were conducted in the databases of MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), PSYCinfo, Scopus, Web of Science, and for articles published from inception to June 30, 2016. Primary outcomes of interest were the use of PPIs and di..

View full abstract